Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v7-FR | Version v3-EN | |
---|---|---|
Language | French | English |
Date Updated | 2021-05-21 | 2021-04-23 |
Drug Identification Number | 02043440 | 02043440 |
Brand name | PREMARIN VAGINAL CREAM | PREMARIN VAGINAL CREAM |
Common or Proper name | Premarin | Premarin |
Company Name | PFIZER CANADA ULC | PFIZER CANADA ULC |
Ingredients | CONJUGATED ESTROGENS | CONJUGATED ESTROGENS |
Strength(s) | 0.625MG | 0.625MG |
Dosage form(s) | CREAM | CREAM |
Route of administration | VAGINAL VAGINAL | VAGINAL VAGINAL |
Packaging size | 30g Tube | 30g Tube |
ATC code | G03CA | G03CA |
ATC description | ESTROGENS | ESTROGENS |
Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-05-19 | 2021-05-19 |
Actual start date | 2021-05-21 | |
Estimated end date | Unknown | Unknown |
Actual end date | ||
Shortage status | Anticipated shortage | Anticipated shortage |
Tier 3 Status | No | No |
Company comments | Available inventory is on preventative allocation until depletion (approx mid May 2021). Partial replenishments are expected to be available as of July 2021, however full recovery is expected by the end of the year. | Available inventory is on preventative allocation until depletion (approx mid May 2021). Partial replenishments are expected to be available as of July 2021, however full recovery is expected by the end of the year. |
Health Canada comments |